TABLE 3.
The IC50 value of TBMS-1 in various types of tumor cells.
| Cell line | IC50 value | Application | References |
|---|---|---|---|
| NCI-H1299 lung cancer cells | 17.53 μmol/L | In vitro | Wang et al. (2020a) |
| NCI-H1975 lung cancer cells | 25.01 μmol/L | In vitro | Wang et al. (2020a) |
| A549 lung cancer cells | 12.30 μmol/L | In vitro | Hao et al. (2015) |
| PC9 lung cancer cells | 10.20 μmol/L | In vitro | Hao et al. (2015) |
| NCI-H460 lung cancer cells | 23.30 μmol/L | In vitro | Gu et al. (2016) |
| PGCL3 lung cancer cells | 15.70 μmol/L | In vitro | Yu et al. (2008) |
| A549/DDP cells | 12.44 μg/ml | In vitro | Wang et al. (2020b) |
| CNE-2Z nasopharyngeal cancer cells | 32.5 μmol/L | In vitro | Weng et al. (2003) |
| SCC15 oral cancer cells | 11.6 μmol/L | In vitro | Wu et al. (2018) |
| CAL27 oral cancer cells | 14.6 μmol/L | In vitro | Wu et al. (2018) |
| EC109 esophageal cancer cells | 45 μmol/L | In vitro | Xu et al. (2013) |
| HepG2 liver cancer cells | 15.5 μmol/L | In vitro | Wang et al. (2011b) |
| U251 glioma cells | 31.55 μg/ml | In vitro | Cao et al. (2020) |
| HeLa cervical cancer cells | 34.8 μmol/L | In vitro | Wang et al. (2006b) |
| A2780/DDP cells | 16.10 μmol/L | In vitro | Liu et al. (2011b) |
| SKOV-3 ovarian cancer cells | 16 μmol/L | In vitro | Chen et al. (2012) |
| Choriocarcinoma JEG-3 cells | 8.5 μmol/L | In vitro | Huang et al. (2011) |
| Prostate carcinoma DU145 cells | 10 μmol/L | In vitro | Yang et al. (2016) |
| Prostate carcinoma PC3 cells | 20 μmol/L | In vitro | Yang et al. (2016) |
| Leukemia K562 cells | 19.7 μmol/L | In vitro | Liu et al. (2006) |
| Leukemia HL-60 cells | 2.4 μmol/L | In vitro | Yu et al. (1996) |
| Melanoma MV3 cells | 12 μmol/L | In vitro | Du et al. (2020) |
| Melanoma A375 cells | 8 μmol/L | In vitro | Du et al. (2020) |